People | December 14, 2023
Moderna Chief Commercial Officer steps down, President to look over pipeline strategy
Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025
Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025
Leading USA based genetic testing brand officially enters the Indian market
Dr. Reddy's Laboratories has been issued a Form 483 with three observations
NATCO temporarily shut down the operations due to cyclone with flooding/water logging of the factory premises
The company is assessing the situation and simultaneously undertaking all the requisite action
The company has received Form 483 with three observations
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Both the India and GCC entities will be operated by separate dedicated management teams
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
Phase 3 data expected in the second half of 2024
Subscribe To Our Newsletter & Stay Updated
